Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0700

+1.4%

Nov 21 3:07 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Howard Williams	10/17/2012 4:47:12 PM
	1 Recommendation Read Replies (2) of 13111

press release Oct. 17, 2012, 4:38 p.m. EDT Provectus Pharmaceuticals Terminates Proposed Convertible Preferred Stock Offering KNOXVILLE, Tenn., Oct 17, 2012 (BUSINESS WIRE) -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, pvct.com ), a development-stage oncology and dermatology biopharmaceutical company, announces the termination of its proposed convertible preferred stock offering because of current market conditions. Provectus filed a preliminary prospectus supplement with the Securities and Exchange Commission on September 4, 2012, with respect to the proposed offering. As disclosed in the Company's filings with the Securities and Exchange Commission, the Company expects to seek additional financing to fund its operations.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next